SSY GROUP(02005): Indigo green has been approved for registration as an active pharmaceutical ingredient for use in marketed preparations.
Stone Four Medicine Group (02005) announced that the group's indocyanine green has been approved and registered by the China National Medical Products Administration...
The SSY Group (02005) announced that their indocyanine green has been approved by the China National Medical Products Administration for registration as a raw material for use in marketed formulations.
Indocyanine green can be used for diagnosing various liver diseases such as cirrhosis, liver fibrosis, chronic hepatitis, occupational and drug-induced liver diseases to understand the extent of liver damage and its reserve function;
It can also be used for choroidal angiography to determine the location of choroidal diseases.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
